These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7254231)

  • 1. Cross-reactivity of anti-acetylcholine receptor autoantibodies.
    Garlepp MJ; Kay PH; Dawkins RL; Bucknall RC; Kemp A
    Muscle Nerve; 1981; 4(4):282-8. PubMed ID: 7254231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
    Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Jul; 41(1):13-8. PubMed ID: 6777100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor.
    Vernet-der Garabedian B; Lacokova M; Eymard B; Morel E; Faltin M; Zajac J; Sadovsky O; Dommergues M; Tripon P; Bach JF
    J Clin Invest; 1994 Aug; 94(2):555-9. PubMed ID: 8040310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis.
    Krolick KA; Yeh TM; Edlund SA
    Cell Immunol; 1996 Aug; 172(1):10-20. PubMed ID: 8806801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
    Poulas K; Koutsouraki E; Kordas G; Kokla A; Tzartos SJ
    J Neuroimmunol; 2012 Sep; 250(1-2):94-8. PubMed ID: 22683336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro effects of D-penicillamine upon anti-AChR production by thymic and peripheral blood lymphocytes from patients with myasthenia gravis.
    Scadding GK; Calder L; Newsom-Davis J
    Muscle Nerve; 1983; 6(9):656-60. PubMed ID: 6606776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G; Maida EM
    Z Rheumatol; 1986; 45(3):118-21. PubMed ID: 3751350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines.
    Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S
    Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
    Penn AS; Schotland DL; Lamme S
    Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-acetylcholine receptor antibodies induced in mice by syngeneic receptor without adjuvants.
    Scadding GK; Calder L; Vincent A; Prior C; Wray D; Newsom-Davis J
    Immunology; 1986 May; 58(1):151-5. PubMed ID: 3486818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented anti-acetylcholine receptor response following long-term penicillamine administration.
    Bever CT; Dretchen KL; Blake GJ; Chang HW; Penn AS; Asofsky R
    Ann Neurol; 1984 Jul; 16(1):9-13. PubMed ID: 6431900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to acetylcholine receptor in canine and human myasthenia gravis: differential cross-reactivity with human and rabbit receptor.
    Dau PC; Yano CS; Ettinger SJ
    Neurology; 1979 Jul; 29(7):1065-8. PubMed ID: 572937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid molecules.
    Sterz R; Hohlfeld R; Rajki K; Kaul M; Heininger K; Peper K; Toyka KV
    Muscle Nerve; 1986 May; 9(4):306-12. PubMed ID: 2423869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.